Skip to main content

Want a detailed portfolio tracker?

Bolt Biotherapeutics (BOLT) P/E (2021 - 2026)

Bolt Biotherapeutics (BOLT) P/E from Feb 5, 2021 to Jul 22, 2026. The TTM Bolt Biotherapeutics (BOLT) P/E is -0.27. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Bolt Biotherapeutics (BOLT)

YearP/EChange
2026-0.27-15.53%
2025-0.31-3.07%
2024-0.32-45.48%
2023-0.60+16.16%
2022-0.51-72.18%
2021-1.84N/A

Comparison Bolt Biotherapeutics (BOLT) P/E with competitors

Bolt Biotherapeutics (BOLT) P/E is -0.27.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.64%
NBYStablecoin Development Corp0.00-101.62%
ENLVEnlivex Ltd0.07-128.16%
FGENFibroGen Inc0.24-190.38%
CHRSCoherus Biosciences Inc0.85-419.47%
FBIOFortress Biotech Inc0.95-457.31%
ORMPOramed Pharmaceuticals Inc1.50-665.90%
AGENAgenus Inc3.01-1233.11%
INVAInnoviva Inc3.15-1287.48%
VXRTVaxart Inc3.55-1436.47%
CRMDCorMedix Inc3.63-1466.10%
CVACCureVac N.V.4.45-1773.78%
GLPGGalapagos NV4.86-1929.36%
SRPTSarepta Therapeutics Inc4.88-1938.09%
ABEOAbeona Therapeutics Inc5.39-2128.38%
ABUSArbutus Biopharma Corp5.60-2206.73%
ZVRAZevra Therapeutics Inc5.89-2316.52%
SPROSpero Therapeutics Inc6.23-2444.99%
CGENCompugen Ltd6.31-2477.18%
RIGLRigel Pharmaceuticals6.87-2687.31%
SLXNSilexion Therapeutics Corp7.30-2846.95%
OMEROmeros Corporation9.26-3585.90%
AUPHAurinia Pharmaceuticals Inc9.58-3708.71%
PLXProtalix BioTherapeutics Inc10.89-4200.44%
ACADAcadia Pharmaceuticals Inc11.73-4515.77%
TBPHTheravance Biopharma Inc12.26-4716.67%
ADMAAdma Biologics Inc12.42-4775.41%
HRMYHarmony Biosciences Holdings Inc13.82-5303.28%
SABSSAB Biotherapeutics Inc14.14-5422.26%
NAGENiagen Bioscience Inc14.82-5679.00%
INCYIncyte Corp15.82-6057.17%
REGNRegeneron Pharmaceuticals Inc15.86-6070.01%
PBYIPuma Biotechnology Inc17.32-6619.34%
CPRXCatalyst Pharmaceuticals Inc17.44-6665.88%
EXELExelixis Inc17.54-6703.04%
TGTXTG Therapeutics Inc18.97-7240.70%
MDXGMimedx Group Inc20.55-7837.99%
XOMAXOMA Royalty Corp22.87-8712.52%
ARGXArgen X SE24.30-9248.41%
CTMXCytomX Therapeutics Inc24.82-9445.36%
XOMAOXOMA Royalty Corp25.34-9642.54%
HALOHalozyme Therapeutics Inc25.62-9747.55%
XOMAPXOMA Royalty Corp25.67-9765.02%
VRTXVertex Pharmaceuticals Inc27.99-10640.26%
RPRXRoyalty Pharma plc - Class A28.69-10901.11%
SLNOSoleno Therapeutics Inc29.02-11024.53%
ASNDAscendis Pharma A/S30.09-11427.47%
LGNDLigand Pharmaceuticals Inc - Class B37.91-14374.20%
APLSApellis Pharmaceuticals Inc39.02-14791.83%
BMRNBiomarin Pharmaceutical Inc42.21-15993.13%
KRYSKrystal Biotech Inc45.34-17172.21%
ONCBeiGene Ltd69.54-26282.59%
PHARPharming Group N.V.75.03-28347.79%
TECHBio-Techne Corp101.96-38488.23%
VCELVericel Corp109.92-41486.36%
ALNYAlnylam Pharmaceuticals Inc117.96-44514.91%
GMABGenmab140.29-52920.72%
TLXTelix Pharmaceuticals Ltd162.15-61151.98%
CORTCorcept Therapeutics Inc212.86-80242.75%